Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis.
about
Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and woundsMutations of PIK3CA in gastric adenocarcinomaA DNA microarray survey of gene expression in normal human tissues.From bench to clinic and back: Perspective on the 1st IQPC Translational Research conferenceA mouse stromal response to tumor invasion predicts prostate and breast cancer patient survivalCancer evolution and individual susceptibilityA gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patientsPromoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIAMolecular classification of gastric cancer: a new paradigm.Gene expression patterns in pancreatic tumors, cells and tissues.Coexpression analysis of human genes across many microarray data setsIdentification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data.A transgenic mouse model of metastatic carcinoma involving transdifferentiation of a gastric epithelial lineage progenitor to a neuroendocrine phenotypeIdentification of genes differentially expressed in rat alveolar type I cells.Comparison of gene-expression profiles between diffuse- and intestinal-type gastric cancers using a genome-wide cDNA microarray.Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer.Secretory phospholipase A2 enzymes as pharmacological targets for treatment of diseaseInhibitory effect of cisplatin and [Pt(dach)Cl2] on the activity of phospholipase A2.Modifier genes and the plasticity of genetic networks in mice.Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma.Molecular profiling of hepatocellular carcinomas by cDNA microarray.Production of vascular endothelial growth factors from human lung macrophages induced by group IIA and group X secreted phospholipases A2Variation in gene expression patterns in human gastric cancers.A new era of secreted phospholipase A₂Genomic perspective and cancer.Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy.A perspective on DNA microarrays in pathology research and practiceExpression of secreted phospholipase A2-Group IIA correlates with prognosis of gastric adenocarcinoma.Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a biomarker candidate.Differential expression of secretory phospholipases A2 in normal and malignant prostate cell lines: regulation by cytokines, cell signaling pathways, and epigenetic mechanismsMolecular staging of gastric cancer.Antiproliferative Activity of Triterpene Glycoside Nutrient from Monk Fruit in Colorectal Cancer and Throat CancerHow form follows functional genomics: gene expression profiling gastric epithelial cells with a particular discourse on the parietal cellSystems Pharmacology Dissection of the Integrated Treatment for Cardiovascular and Gastrointestinal Disorders by Traditional Chinese MedicineAPC and its modifiers in colon cancer.Liposomal cancer therapy: exploiting tumor characteristics.Enzyme-triggered nanomedicine: drug release strategies in cancer therapy.Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples.A genome-wide map of aberrantly expressed chromosomal islands in colorectal cancer.Genomics Study of Gastric Cancer and Its Molecular Subtypes.
P2860
Q21146433-C23AA944-7533-457A-9BA5-6A1D7D951B55Q21261219-50DF8664-1F82-436F-8DD9-260855718F2FQ24797220-EF89A7B1-79A9-40C6-BC79-3BC0D4521036Q24803350-231240A8-CC68-4B9A-B54E-12F00DFF91ABQ27303204-1BDAAE86-F16B-409B-BBA1-3C0410CFFBA2Q28389946-E556888D-F751-421D-AACE-1083E8F0725CQ28477202-23412170-671A-4987-A2F9-81819AC5AD6DQ28564096-257F8ED5-CAB3-41EC-B94E-8BAA0678283BQ30500375-5A79D84C-0304-458A-BC7D-2B3BD892E418Q30830632-6240BD04-CE8F-41AD-A133-78CD5EC5D2AEQ30936126-B5EEB501-5DE3-4FB7-9580-8293C89E8480Q30983130-C146CDAA-33C9-4123-887D-FDF975335AE2Q33201186-F2C26EBD-5D3E-4524-80C9-DB6A8C41604EQ33203897-8DFCC2C4-1DC7-4F3F-9CEC-99E26609E3BDQ33205161-1D663749-5018-46BF-AAB1-8B94916F0075Q33557996-72FDE87B-E1D6-40CF-A63D-E917D3FC0ADDQ33923169-94D7B1F5-F631-414F-BBA3-37AFF752E666Q34198269-D1692EAA-EBA5-44CB-A831-FF4692D6F693Q34236664-F1776276-6FC6-405D-95AD-CFD60E3B8019Q34268571-6419526C-B30A-4DA1-A037-DD5A3ECA8129Q34605680-39493575-88A9-436D-9D84-11B5379C40BEQ34776384-F42148BF-E3CE-4019-9D4F-73045A5D5672Q35670324-F06AAEC9-1F9A-412E-A5D2-323F0792126CQ35776615-405D6058-7ED7-4970-9E99-E63F81365C17Q35875188-5DD30E30-BD8F-44A8-AA15-6FB880412D31Q35875892-07D998AE-9AC1-47D0-8D0E-4DCB56CE6500Q35916012-976AC2B4-C9C6-442A-BA23-719E6DC527B7Q36335600-D71A7B8D-F89A-4937-B5BE-2DDB702D9AB0Q36459773-AE55B8DD-F51E-40E8-8501-937F4FE1A640Q36485297-53FE6688-00DA-403B-99CA-C3128E12DC30Q36940064-4CAA52CD-716B-47E4-9ECB-A3D6884910A7Q37045159-11B4DE00-98DA-4A1F-9913-629A5F84C68AQ37200599-5810581C-F514-4303-8C89-5E861CD2B216Q37232687-A79E3C8A-7A02-451B-BFF4-0101F827A329Q37635945-229A3B5A-ECC3-4A6A-93FA-319D3E4FD7D6Q37679954-15C5C798-6C98-4B56-B0A7-0C9B3AA1E6FEQ37799614-20F23858-E0DC-4DD4-A17D-7FE4D2431519Q38359626-78B583B1-F31B-471F-930A-70ADCA658338Q38582323-0E11198D-32C7-4300-911A-7D50709A8931Q38826577-BD4107E0-C9DF-408F-8B40-460CB6F5719C
P2860
Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Phospholipase A2 group IIA exp ...... and less frequent metastasis.
@ast
Phospholipase A2 group IIA exp ...... and less frequent metastasis.
@en
Phospholipase A2 group IIA exp ...... and less frequent metastasis.
@nl
type
label
Phospholipase A2 group IIA exp ...... and less frequent metastasis.
@ast
Phospholipase A2 group IIA exp ...... and less frequent metastasis.
@en
Phospholipase A2 group IIA exp ...... and less frequent metastasis.
@nl
prefLabel
Phospholipase A2 group IIA exp ...... and less frequent metastasis.
@ast
Phospholipase A2 group IIA exp ...... and less frequent metastasis.
@en
Phospholipase A2 group IIA exp ...... and less frequent metastasis.
@nl
P2093
P2860
P50
P356
P1476
Phospholipase A2 group IIA exp ...... and less frequent metastasis.
@en
P2093
Annie S Y Chan
Jonathan Mathy
Kent M Chu
Siu T Yuen
Suet Y Leung
P2860
P304
16203-16208
P356
10.1073/PNAS.212646299
P407
P577
2002-11-27T00:00:00Z